Merck KGaA is a global pharmaceutical and chemical company which includes Merck Serono Biopharmaceuticals and consumer health care products. Its chemicals business operates via two divisions; Liquid Crystals (LC) and Performance and Life Sciences Chemicals. 
Its future investments will remain high in order to ensure the long-term growth of the company through innovation. Research intensity (research spending divided by sales) should remain at more than 10% and at approximately 25% for its ethical business.
Within the chemicals business sector, Merck sees its prospects as looking very good in its high-grade liquid crystals business and believes it will continue to grow, thanks to the huge demand for specialised liquid crystal materials for PC monitors and large-format television screens, as well as the addition of colour filters to the product range.
Headquartered in Darmstadt, Germany, Merck had sales of nearly Euro7.5bn in 2008 and around 32,800 employees (including Merck Serono) in 60 countries.
ICIS Chemical Business magazine has unveiled the ICIS Top 100 Chemical Companies, with rankings based on 2008 sales.
A PDF of the ICIS Top 100 Chemical Companies is available for download on ICIS connect.
See the article and analysis of the ICIS Top 100 on ICIS news.
Key Personnel
Member: Karl-Ludwig Kley
Member: Michael Becker
Member: Bernd Reckmann
Member: Elmar Schnee
(Updated September 2009)
Contacts
Merck KGaA
Frankfurter Street 250
D-64293 Darmstadt
Germany
Tel: +49 6151 72 0
Fax: +49 6151 72 2000
Email: service@merck.de
http://pb.merck.de
Merck KGaA
Company Structure
Merck is a global pharmaceutical and chemical company. Merck's roots go back to the year 1668, when Friedrich Jacob Merck purchased the “Engel-Apotheke” (Angel Pharmacy) in Darmstadt, which has been in the possession of the family ever since. In 1816, Emanuel Merck took over the pharmacy. From these beginnings, he and his successors gradually built up a chemical-pharmaceutical factory that produced (in addition to raw materials for pharmaceutical preparations) a multitude of other fine chemicals, and ready-to-use medicines from 1904.
More about Merck KGaA Structure
Merck KGaA
Strategy & Financial Highlights
Merck KGaA’s strategy focuses on diversification. It further focuses on innovative areas, such as liquid crystals. Merck KGaA will continue to invest in research and development (R&D) - investments that it says will open new opportunities for the company. (Edited from annual report). ICIS also provides you with key financial data listed in table form.
More about Merck KGaA Strategy & Financial Highlights
News:
Get news on Merck KGaA plus the latest chemical news, information, data, market movements and analysis
in one place with ICIS news
Search:
Find details on other chemical companies and suppliers with
ICIS search
Newsletters:
ICIS offers a range of FREE e-newsletters to ensure that you don't miss out on the latest development and key market intelligence in your industry. If you want the latest news sent to your inbox, sign up for ICIS e-newsletters today.
Plants and projects:
Find out more about current and planned chemical plants and projects by subscribing to our comprehensive database